Alzheimer’s drug trials have a long and disappointing track record, with many failing to prove effective. But results released last week from an Alzheimer’s study bolstered hopes. Reisa Sperling, professor of neurology at Brigham and Women’s Hospital, is leading the study. Keith Johnson, professor of radiology at Massachusetts General Hospital, is leading the tau imaging for the study.
